Observational study of genetic variants in neurodevelopmental disorders
Official title: Neurogenetic Disorders: A Longitudinal Study on Natural History and Intervention Strategies
Run by Columbia University · NCT03492060 · Data updated 2026-11-12
This study looks at how certain genetic changes affect people with neurodevelopmental disorders like autism and intellectual disabilities to better understand their treatment and related health issues.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | June 13, 2018 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | October 27, 2025 |
| Trial ID | NCT03492060 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with confirmed genetic variants linked to neurodevelopmental disorders.
✕Probably not a fit
Patients without a confirmed genetic variant or those unable to provide genetic confirmation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to analyze patterns in individuals with specific genetic variants associated with neurodevelopmental disorders, including autism and intellectual disabilities. It will maintain an ongoing database of medical data collected during routine care and gather prospective data through questionnaires, neuropsychological assessments, and electroencephalography. The focus is on understanding the neurological comorbidities and treatment outcomes related to these genetic variants. The study will include individuals with confirmed variants in any gene presenting with neurodevelopmental abnormalities.
Why it matters
Potential benefit: If successful, this study could enhance understanding of neurodevelopmental disorders and improve patient management strategies.
How similar studies have gone: Other studies have shown success in understanding genetic contributions to neurodevelopmental disorders, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals must have had whole genome/exome sequencing and have a confirmed variant in any gene. Exclusion Criteria: * Subjects who cannot provide genetic confirmation of a predicted deleterious variant in any gene.
Where it's running
-
Columbia University Irving Medical Center
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Jennifer M. Bain, MD, PhD — Columbia University
- Study coordinator: Jennifer M. Bain, MD, PhD
- Email: jb3634@cumc.columbia.edu
- Phone: 646-426-3876
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Inclusive physical activity program for adults with intellectual disabilities
This study is testing a new fitness program for adults with intellectual disabilities to see if it helps them be more active and feel better over 16 weeks.
-
Online self-instructional program for kindergarten and elementary teachers to support autistic children and children with developmental delays
This program tests whether an online, self-guided training helps K–5 public school teachers improve their knowledge, attitudes, and confidence in supporting autistic children and children with developmental delays.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
-
Using preferred communication tools to reduce challenging behavior
This project will test whether using a person's favored communication tool (for example a touch talker or picture cards) helps keep behavior improvements and prevents relapse in people with intellectual or developmental disabilities who have little or no verbal speech.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.